157 related articles for article (PubMed ID: 38448411)
1. The RNA m
Ge L; Rui Y; Wang C; Wu Y; Wang H; Wang J
Cell Death Dis; 2024 Mar; 15(3):192. PubMed ID: 38448411
[TBL] [Abstract][Full Text] [Related]
2. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability.
Yang F; Ma Q; Huang B; Wang X; Pan X; Yu T; Ran L; Jiang S; Li H; Chen Y; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Li W; Xiao B
J Transl Med; 2023 Jun; 21(1):402. PubMed ID: 37340423
[TBL] [Abstract][Full Text] [Related]
3. CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA-protein ternary complex.
Ma Q; Yang F; Huang B; Pan X; Li W; Yu T; Wang X; Ran L; Qian K; Li H; Li H; Liu Y; Liang C; Ren J; Zhang Y; Wang S; Xiao B
J Exp Clin Cancer Res; 2022 Aug; 41(1):251. PubMed ID: 35986300
[TBL] [Abstract][Full Text] [Related]
4. IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m
Chen LJ; Liu HY; Xiao ZY; Qiu T; Zhang D; Zhang LJ; Han FY; Chen GJ; Xu XM; Zhu JH; Ding YQ; Wang SY; Ye YP; Jiao HL
Cell Death Dis; 2023 Sep; 14(9):581. PubMed ID: 37658049
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N
Zhang J; Yang K; Bu J; Yan J; Hu X; Liu K; Gao S; Tang S; Gao L; Chen W
Front Oncol; 2022; 12():1035871. PubMed ID: 36313631
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis.
Zhou Y; Huang T; Siu HL; Wong CC; Dong Y; Wu F; Zhang B; Wu WK; Cheng AS; Yu J; To KF; Kang W
Mol Cancer; 2017 Apr; 16(1):77. PubMed ID: 28399871
[TBL] [Abstract][Full Text] [Related]
8. The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance.
Zhang J; Ding F; Jiao D; Li Q; Ma H
Technol Cancer Res Treat; 2020; 19():1533033820917332. PubMed ID: 32266868
[TBL] [Abstract][Full Text] [Related]
9. Isoliquiritigenin inhibits non-small cell lung cancer progression via m
Cui Y; Wu Y; Wang C; Wang Z; Li Y; Jiang Z; Zhao W; Pan Z
Phytomedicine; 2022 Sep; 104():154299. PubMed ID: 35816995
[TBL] [Abstract][Full Text] [Related]
10. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.
Zhang X; Chen Q; He Y; Shi Q; Yin C; Xie Y; Yu H; Bao Y; Wang X; Tang C; Dong Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):19. PubMed ID: 36639675
[TBL] [Abstract][Full Text] [Related]
11. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
12.
Gu Y; Niu S; Wang Y; Duan L; Pan Y; Tong Z; Zhang X; Yang Z; Peng B; Wang X; Han X; Li Y; Cheng T; Liu Y; Shang L; Liu T; Yang X; Sun M; Jiang S; Zhang C; Zhang N; Ye Q; Gao S
Cancer Res; 2021 Feb; 81(4):923-934. PubMed ID: 33293428
[TBL] [Abstract][Full Text] [Related]
13. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
[TBL] [Abstract][Full Text] [Related]
15. Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
Shi R; Yu X; Wang Y; Sun J; Sun Q; Xia W; Dong G; Wang A; Gao Z; Jiang F; Xu L
Tumour Biol; 2017 Apr; 39(4):1010428317695928. PubMed ID: 28381175
[TBL] [Abstract][Full Text] [Related]
16. The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability.
Zhang N; Shen Y; Li H; Chen Y; Zhang P; Lou S; Deng J
Exp Mol Med; 2022 Feb; 54(2):194-205. PubMed ID: 35217832
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule exhibits anti-tumor activity by targeting the RNA m
Shu C; Gu MH; Zeng C; Shao WG; Li HY; Ma XH; Li MX; Cao YY; Zhang MJ; Zhao W; Zhao SL
Am J Cancer Res; 2023; 13(10):4888-4902. PubMed ID: 37970340
[TBL] [Abstract][Full Text] [Related]
18. RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferation.
Zhu K; Gao T; Wang Z; Zhang L; Tan K; Lv Z
Cell Death Discov; 2023 May; 9(1):151. PubMed ID: 37156775
[TBL] [Abstract][Full Text] [Related]
19. IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.
Huang W; Li Y; Zhang C; Zha H; Zhou X; Fu B; Guo J; Wang G
J Cell Mol Med; 2020 Dec; 24(23):13949-13960. PubMed ID: 33094561
[TBL] [Abstract][Full Text] [Related]
20. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
